2024-12-08
27 分钟Dr Daniela Marino is the CEO and co-founder of skin-graft innovators Cutiss and one of the inspirational leaders that UBS supports and celebrates through its Global Visionaries programme. Marino is joined at Monocle’s HQ in Zürich by Tom Hall, global head of social impact at UBS, to discuss Cutiss’s success in this year’s UBS Pitch for Purpose event and why it’s important for UBS to champion individuals who are driving solutions to the great challenges of the day. See omnystudio.com/listener for privacy information.
Hello and welcome to the Bulletin with UBS on Monocle Radio.
Each week, the sharpest minds and freshest thinkers in finance take you beyond the numbers and hype right to the heart of the big issues of the day.
This week we have a very special edition for you as we're meeting another of the inspirational thought leaders and innovators that UBS supports and celebrates through its Global Visionaries program.
This time it's the turn of Dr.
Daniela Marino, CEO and co founder of Skingraft Innovators Cootis.
The current standard of care for severe burns is skin autografting, a rather dated technique with suboptimal patient outcomes.
With its revolutionary processes, Kutis addresses the unmet needs of those patients with such injuries by bioengineering patients human skin tissue.
Kutis main product is the revolutionary de novo skin.
Originally from southern Italy, Dr.
Mourinho is also a mother of two.
In addition to her day job growing the company, Daniela holds a Master's in Biotech and a PhD in Sciences from Etihad in Zurich.
Daniela called in at Monacle's own HQ in the city to explain more about her work and objectives and to reflect on her success as the winner of the most recent UBS Pitch for Purpose event where a group of global visionaries pitch their vision for positive social and environmental impact to an audience made up of UBS clients interested in impact topics, investors and startup ecosystem builders.
Dr.
Marino and Kutis were picked as the winner of a one to one coaching program and a prestigious speaking opportunity at next year's UBS Social Impact Forum, joining Daniela in the Monocle Radio studio.
And as ever, a very welcome returning guest on this program was Tom Hall, Global Head of Social Impact at UBS and the CEO of the UBS Optimus Foundation Network.
Monocle's Chris chamak welcomed both Dr.
Marino and Tom to the Zurich branch of Monocle and he began by asking Daniela to introduce herself and explain the start of her story.
I am the CEO and the co founder of a Swiss based company called Kutis.
I am a biotechnologist by background, did my studies in Milano, I come from South Italy and then came to Switzerland for my PhD at the ETH and my idea was to go to the US and take my academic career to a start.
But instead I decided to stay a little bit longer in Zurich.